Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

012022-04

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
312022-03

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
212022-03

NOTICE OF BOARD MEETING The board of directors (the “Board”) of Charmacy Pharmaceutical Co., Ltd.
022022-03

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
282022-02

Profit Warning
252022-02

CHANGE OF PROCESS AGENT
152022-02

INSIDE INFORMATION-PROPOSED PARTICIPATION IN THE H SHARE FULL CIRCULATION PROGRAMME BY THE COMPANY
072022-02

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
062022-01

VOLUNTARY ANNOUNCEMENT TRANSFER OF DOMESTIC SHARES BY DOMESTIC SHAREHOLDERS
042022-01

ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE, RULE 13.09(2)(a) OF THE LISTING RULES AND INSIDE INFORMATION PROVISIONS UNDER PART XIVA OF THE SFO AND END OF OFFER PERIOD
042022-01

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
202021-12

MONTHLY UPDATE ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE

12 13 14 15 16

The Enterprise OA